Overview
David Irvine practices in Glasgow, United Kingdom. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Non-Hodgkin Lymphoma, T-Cell Lymphoma, and Diffuse Large B-Cell Lymphoma (DLBCL).
His clinical research consists of co-authoring 17 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- B-Cell LymphomaMr. Irvine isExperienced. Learn about B-Cell Lymphoma.
- Chronic Myelogenous Leukemia (CML)Mr. Irvine isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Diffuse Large B-Cell Lymphoma (DLBCL)Mr. Irvine isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- LeukemiaMr. Irvine isExperienced. Learn about Leukemia.
- Non-Hodgkin LymphomaMr. Irvine isExperienced. Learn about Non-Hodgkin Lymphoma.
- Peripheral T-Cell LymphomaMr. Irvine isExperienced. Learn about Peripheral T-Cell Lymphoma.